Fulgent registered logo
Fulgent Pharma logo
About Us
Technology
Pipeline
Careers
Management
News & Events
Contact Us
Fulgent Pharma Logo.
Mobile menu button.
Fulgent Pharma Logo.
Mobile menu button close.
Fulgent registered logo
Pipeline
Summary
Pipeline graphic of FID-007 drug candidate
Milestones
Head & Neck: Began Phase 2 enrollment in 2024
Ampullary or ICI Resistant: Go/no-go based on H&N study
Pipeline graphic of FID-022 drug candidate
Milestones
Begin Phase 1 enrollment in mid-2025
Pipeline graphic of ADC drug candidate